T1	Participants 73 131	overweight and obese subjects with cardiovascular disease.
T2	Participants 313 407	overweight and obese subjects receiving long-term sibutramine treatment with diet and exercise
T3	Participants 631 726	9804 male and female subjects, aged 55 years or older, with a body mass index of 27-45 kg m(-2)
T4	Participants 822 1002	history of cardiovascular disease and/or type 2 diabetes mellitus with at least one cardiovascular risk factor (hypertension, dyslipidemia, current smoking or diabetic nephropathy)
T5	Participants 1831 1874	increases in both weight and blood pressure
T6	Participants 2224 2272	obese elderly cardiovascular diseased population
